Vaccine Adjuvants

Global Market Trajectory & Analytics

MCP15427

EXECUTIVE ENGAGEMENTS

POOL

502
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

102
Interactions with Platform & by Email

PARTICIPANTS

22
Unique # Participated

VALIDATIONS

8
Responses Validated*

COMPANIES

44
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

201

PAGES

275

EDITION

7

PRICE

USD 5450

CODE

MCP15427


COMPETITIVE METRICS

COMPANY

D S N T

% *

Adjuvance Technologies

Agenus, Inc.

Avanti Polar Lipids, Inc.

CSL Ltd.

HanaVax

Idera Pharmaceuticals, Inc.

Invivogen

Mvp Laboratories Inc.

Novavax, Inc.

OZ Biosciences SAS

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Vaccine Adjuvants estimated at US$619.7 Million in the year 2020, is projected to reach a revised size of US$1.1 Billion by 2027, growing at a CAGR of 9.1% over the analysis period 2020-2027. Particulate Adjuvants, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$386.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Adjuvant Emulsions segment is readjusted to a revised 10.2% CAGR for the next 7-year period.
The Vaccine Adjuvants market in the U.S. is estimated at US$183.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$197.8 Million by the year 2027 trailing a CAGR of 8.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.5% and 7.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.
In the global Pathogen Components segment, USA, Canada, Japan, China and Europe will drive the 8.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$94.1 Million in the year 2020 will reach a projected size of US$164 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$132 Million by the year 2027.

SELECT PLAYERS

Agenus, Inc.; Avanti Polar Lipids, Inc.; Brenntag Biosector A/S; CSL Ltd.; Invivogen; Mvp Laboratories Inc.; Novavax, Inc.; OZ Biosciences SAS; Seppic SA; SPI Pharma

SEGMENTS

» Type (Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants, Other Types) » Category (Human, Veterinary) » Disease Type (Infectious Diseases, Cancer, Other Disease Types) » Application (Research, Commercial)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vaccine Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Particulate Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Particulate Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Particulate Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Adjuvant Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Adjuvant Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Adjuvant Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pathogen Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Pathogen Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pathogen Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Combination Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Combination Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Combination Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Subcutaneous by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Subcutaneous by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Intramuscular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Intramuscular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intramuscular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Intranasal Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Intranasal Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Intranasal Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Oral Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oral Route by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oral Route by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Route of Administrations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Route of Administrations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Disease Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Disease Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Human Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Human Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Human Vaccine Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Veterinary Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Veterinary Vaccine Adjuvants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Veterinary Vaccine Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
China Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
China Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
China Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
China Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Vaccine Adjuvants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
France Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
France Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
France Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
France Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Vaccine Adjuvants by Type - Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Vaccine Adjuvants by Type - Percentage Breakdown of Value Sales for Particulate Adjuvants, Adjuvant Emulsions, Pathogen Components, Combination Adjuvants and Other Types for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Vaccine Adjuvants by Route Of Administration - Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Vaccine Adjuvants by Route Of Administration - Percentage Breakdown of Value Sales for Subcutaneous, Intramuscular, Intranasal Route, Oral Route and Other Route of Administrations for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Vaccine Adjuvants by Disease Type - Infectious Diseases, Cancer and Other Disease Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Vaccine Adjuvants by Disease Type - Percentage Breakdown of Value Sales for Infectious Diseases, Cancer and Other Disease Types for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Vaccine Adjuvants by Application - Research and Commercial - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Vaccine Adjuvants by Application - Research and Commercial Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Vaccine Adjuvants by Application - Percentage Breakdown of Value Sales for Research and Commercial for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Vaccine Adjuvants by Application Category - Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Vaccine Adjuvants by Application Category - Percentage Breakdown of Value Sales for Human Vaccine Adjuvants and Veterinary Vaccine Adjuvants for the Years 2012, 2020 & 2027
Total Companies Profiled: 44

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com